Jilin Provincial Cancer Hospital
Changchun, Jilin 130012
1 studies enrolling now · 6 studies all time
What they study most
Advanced Solid Tumors, Breast Cancer, Carcinoma, Non-Small-Cell Lung, Kidney Neoplasms, Non Small Cell Lung Cancer, Non-Small Cell Lung Cancer
Studies at this site
- A Clinical Study of YL205 in Patients With Advanced Solid Tumors — Recruiting now
- A Study of YL202 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer and Breast Cancer — Running, not enrolling
- Study to Evaluate Efficacy & Safety of Afuresertib Plus Fulvestrant in Patients With Locally Advanced or Metastatic HR+/HER2- Breast Cancer — Running, not enrolling
- A Study Of Lorlatinib Versus Crizotinib In First Line Treatment Of Patients With ALK-Positive NSCLC — Running, not enrolling
- Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer — Completed
- ARCHER 1009 : A Study Of Dacomitinib (PF-00299804) Vs. Erlotinib In The Treatment Of Advanced Non-Small Cell Lung Cancer — Completed